EDITORIAL

How to Live for 300 Years: Searching for the Best Way Forward

♥ 16764 Thanks from members

Currently, no single medical protocol guarantees a 300-year lifespan. The realistic strategy is Longevity Escape Velocity: optimizing cellular resilience today to survive until next-generation interventions arrive. Explore evidence-based clinical roadmaps combining therapeutic plasma exchange, epigenetic reprogramming, and somatic organ regeneration.

To live for 300 years and witness the future in optimal health, what is the best roadmap? Here, clinicians, researchers, and network members debate how to combine emerging clinical protocols, navigate biological bottlenecks, and realistically map out an actionable survival strategy.

Member Opinions and Insights

Entity and Market Metadata
Sector: Healthcare and BiotechnologyIndustry: Longevity and Rejuvenation BiotechnologyFounder: Aubrey de GreyFounder: Bryan JohnsonLeadership: Peter Attia (Key Researcher)Leadership: David Sinclair (Key Researcher)Holder: SENS Research FoundationHolder: Human Longevity Inc.Holder: Venture Capital Longevity FundsSenolyticsGene TherapyNAD+ BoostersAI-Driven DiagnosticsCryopreservation#longevity#healthspan#anti-aging#senolytics#life extension#bigerontology